We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
+$159M
Cap. Flow %
3.95%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTC icon
276
Elastic
ESTC
$7.81B
$495K 0.01%
+5,000
New +$462K
CCCC icon
277
C4 Therapeutics
CCCC
$404M
$494K 0.01%
137,360
+114,360
+497% +$569K
CPRI icon
278
PUT
Capri Holdings
CPRI
$1.71B
$494K 0.01%
12,600
WVE icon
279
Wave Life Sciences
WVE
$1.17B
$492K 0.01%
+39,767
New +$531K
ISRG icon
280
Intuitive Surgical
ISRG
$133B
$488K 0.01%
+935
New +$487K
VERA icon
281
Vera Therapeutics
VERA
$2.31B
$488K 0.01%
11,531
-19,921
-63% -$882K
TXN icon
282
Texas Instruments
TXN
$260B
$469K 0.01%
2,500
+1,250
+100% +$250K
NOW icon
283
ServiceNow
NOW
$129B
$464K 0.01%
+2,190
New +$444K
DELL icon
284
Dell
DELL
$289B
$461K 0.01%
+4,000
New +$502K
F icon
285
PUT
Ford
F
$56B
$450K 0.01%
520,900
-50,000
-9% -$533K
CC icon
286
PUT
Chemours
CC
$2.42B
$443K 0.01%
46,900
HYG icon
287
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$438K 0.01%
+1,550,000
New +$123M
DNLI icon
288
Denali Therapeutics
DNLI
$3.86B
$429K 0.01%
21,039
-9,705
-32% -$248K
INO icon
289
Inovio Pharmaceuticals
INO
$67.6M
$412K 0.01%
+225,000
New +$996K
PD icon
290
PagerDuty
PD
$894M
$411K 0.01%
+22,500
New +$431K
BOLD
291
Boundless Bio
BOLD
$63.8M
$406K 0.01%
140,000
+86,832
+163% +$253K
BGS icon
292
PUT
B&G Foods
BGS
$280M
$405K 0.01%
117,500
CATX icon
293
Perspective Therapeutics
CATX
$336M
$393K 0.01%
123,243
+52,320
+74% +$427K
CRGX
294
DELISTED
CARGO Therapeutics
CRGX
$388K 0.01%
26,899
+4,851
+22% +$88K
ARGX icon
295
argenx
ARGX
$55B
$375K 0.01%
610
-1,390
-70% -$814K
CGON icon
296
CG Oncology
CGON
$6.55B
$368K 0.01%
12,834
+1,810
+16% +$61.9K
SLNO
297
DELISTED
Soleno Therapeutics
SLNO
$359K 0.01%
7,977
-7,559
-49% -$392K
MLYS icon
298
Mineralys Therapeutics
MLYS
$2.39B
$346K 0.01%
28,068
-3,000
-10% -$39.2K
MPT
299
PUT
Medical Properties Trust
MPT
$2.79B
$337K 0.01%
396,500
SABR icon
300
PUT
Sabre
SABR
$814M
$331K 0.01%
688,600

Similar funds

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $159M of net new capital in Q4 2024, opening 130 new positions and adding to 130 existing holdings. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

On the sell side, the largest reduction was US Steel, an estimated $62.2M trimmed.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.